Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,715,000 | 3,507,000 | 12,949,000 | 10,235,000 | 6,925,000 |
| Depreciation Amortization | 1,355,000 | 676,000 | 2,832,000 | 2,117,000 | 1,349,000 |
| Income taxes - deferred | 645,000 | 1,212,000 | 22,000 | -354,000 | -322,000 |
| Accounts receivable | -173,000 | -64,000 | -650,000 | -728,000 | -717,000 |
| Other Working Capital | -2,866,000 | -2,727,000 | -1,639,000 | -1,591,000 | -2,270,000 |
| Other Operating Activity | 514,000 | 223,000 | 1,458,000 | 1,292,000 | 1,113,000 |
| Operating Cash Flow | $6,190,000 | $2,827,000 | $14,972,000 | $10,971,000 | $6,078,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -990,000 | -429,000 | -2,281,000 | -1,882,000 | -1,119,000 |
| Net Acquisitions | -1,291,000 | -1,291,000 | -1,214,000 | -400,000 | -46,000 |
| Purchase Of Investment | -3,485,000 | -1,440,000 | -3,668,000 | -1,434,000 | -687,000 |
| Sale Of Investment | 2,471,000 | 2,150,000 | 3,059,000 | 2,079,000 | 1,786,000 |
| Other Investing Activity | -84,000 | -66,000 | -83,000 | -36,000 | -46,000 |
| Investing Cash Flow | $-3,379,000 | $-1,076,000 | $-4,187,000 | $-1,673,000 | $-112,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,082,000 | 3,276,000 | 8,430,000 | 5,194,000 | 3,376,000 |
| Debt Issued | 9,000 | 2,000 | 1,638,000 | 1,640,000 | 1,641,000 |
| Debt Repayment | -16,000 | -9,000 | -24,000 | -16,000 | -5,000 |
| Common Stock Issued | 74,000 | 27,000 | 1,486,000 | 1,360,000 | 610,000 |
| Common Stock Repurchased | -1,123,000 | -834,000 | -6,651,000 | -5,773,000 | -3,617,000 |
| Dividend Paid | -2,623,000 | -1,273,000 | -5,024,000 | -3,750,000 | -2,466,000 |
| Other Financing Activity | -1,331,000 | -1,057,000 | -7,319,000 | -1,649,000 | -837,000 |
| Financing Cash Flow | $-1,928,000 | $132,000 | $-7,464,000 | $-2,994,000 | $-1,298,000 |
| Exchange Rate Effect | 35,000 | -62,000 | -323,000 | -56,000 | 208,000 |
| Beginning Cash Position | 10,768,000 | 10,768,000 | 7,770,000 | 7,770,000 | 7,770,000 |
| End Cash Position | 11,686,000 | 12,589,000 | 10,768,000 | 14,018,000 | 12,646,000 |
| Net Cash Flow | $918,000 | $1,821,000 | $2,998,000 | $6,248,000 | $4,876,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,190,000 | 2,827,000 | 14,972,000 | 10,971,000 | 6,078,000 |
| Capital Expenditure | -1,002,000 | -435,000 | -3,066,000 | -1,938,000 | -1,166,000 |
| Free Cash Flow | 5,188,000 | 2,392,000 | 11,906,000 | 9,033,000 | 4,912,000 |